TABLE 3.
Area under curve (AUC) from receiver operating characteristic (ROC) curve for 90‐day, 180‐day, 1‐year, and 2‐year survival after the surgery.
| Scoring system | All patients | Breast | Lung |
|---|---|---|---|
| 90‐day survival | |||
| Tomita | 0.595 (0.494–0.687) | 0.824 (NA a ) | 0.465 (0.280–0.649) |
| Revised Tokuhashi | 0.650 (0.548–0.745) | 0.922 (NA) | 0.621 (0.437–0.805) |
| Modified Bauer | 0.618 (0.518–0.708) | 0.765 (NA) | 0.478 (0.323–0.633) |
| Revised Katagiri | 0.711 (0.624–0.801) | 0.931 (NA) | 0.623 (0.456–0.789) |
| van der Linden | 0.725 (0.634–0.797) | 0.951 (NA) | 0.556 (0.403–0.710) |
| SORG Nomogram | 0.722 (0.645–0.790) | 0.765 (NA) | 0.617 (0.440–0.794) |
| SORG ML | 0.743 (0.666–0.817) | 0.804 (NA) | 0.665 (0.504–0.801) |
| 180‐day survival | |||
| Tomita | 0.636 (0.564–0.706) | 0.794 (0.673–0.915) | 0.440 (0.301–0.578) |
| Revised Tokuhashi | 0.723 (0.653–0.785) | 0.851 (0.654–1.000) | 0.596 (0.459–0.733) |
| Modified Bauer | 0.671 (0.602–0.739) | 0.787 (0.716–0.859) | 0.511 (0.382–0.640) |
| Revised Katagiri | 0.761 (0.696–0.826) | 0.860 (0.669–1.000) | 0.676 (0.548–0.803) |
| van der Linden | 0.698 (0.624–0.769) | 0.866 (0.733–0.999) | 0.603 (0.481–0.726) |
| 1‐year survival | |||
| Tomita | 0.620 (0.552–0.689) | 0.566 (0.389–0.743) | 0.413 (0.283–0.543) |
| Revised Tokuhashi | 0.702 (0.637–0.767) | 0.644 (0.449–0.839) | 0.531 (0.396–0.667) |
| Modified Bauer | 0.646 (0.575–0.708) | 0.565 (0.392–0.737) | 0.446 (0.325–0.567) |
| Revised Katagiri | 0.759 (0.698–0.814) | 0.702 (0.521–0.883) | 0.660 (0.534–0.785) |
| van der Linden | 0.671 (0.605–0.738) | 0.691 (0.513–0.869) | 0.567 (0.439–0.695) |
| SORG Nomogram | 0.757 (0.696–0.811) | 0.769 (0.628–0.910) | 0.623 (0.490–0.757) |
| SORG ML | 0.787 (0.730–0.838) | 0.740 (0.583–0.886) | 0.793 (0.679–0.879) |
| 2‐year survival | |||
| Tomita | 0.679 (0.639–0.719) | 0.631 (0.548–0.715) | 0.391 (0.300–0.484) |
| Revised Tokuhashi | 0.717 (0.679–0.755) | 0.618 (0.530–0.706) | 0.439 (0.351–0.527) |
| Modified Bauer | 0.678 (0.639–0.717) | 0.620 (0.541–0.700) | 0.378 (0.301–0.455) |
| Revised Katagiri | 0.779 (0.747–0.811) | 0.649 (0.563–0.735) | 0.543 (0.458–0.627) |
| van der Linden | 0.694 (0.657–0.731) | 0.654 (0.573–0.735) | 0.531 (0.448–0.614) |
Note: The SORG nomogram and SORG Machine‐learning do not provide a function for 180‐day and 2‐year survival prediction, so validations of these time points were not performed.
Abbreviation: ML, Machine‐learning; SORG, Skeletal Oncology Research Group.
a
NA: not available to calculate the 95% confidence interval.